2010 discharge: IMI Joint Undertaking for the implementation of the Joint Technology Initiative on Innovative Medicines

A discharge decision concerning the Joint Undertaking for the implementation of the Joint Technology Initiative on Innovative Medicines for the financial year 2010. The amendments grant discharge to the Executive Director and approve the closure of the accounts, note the budget's commitment and payment appropriations and their low implementation and year-end cash balance, and call on the Joint Undertaking to report measures addressing the interim review recommendations.